Tivity Health (TVTY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2021 | 12-2020 | 12-2019 | 12-2018 | 12-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 107,376 | 56,869 | 45,217 | 97,902 | 61,230 |
| Depreciation Amortization | 16,132 | 63,681 | 58,973 | 9,959 | 14,245 |
| Income taxes - deferred | 3,649 | -38,438 | -52,076 | 25,485 | 40,935 |
| Accounts receivable | -36,749 | 63,239 | -8,283 | -12,311 | -3,939 |
| Accounts payable and accrued liabilities | -951 | -3,182 | -10,052 | -95 | -407 |
| Other Working Capital | -24,219 | 42,830 | -35,759 | -32,912 | -16,023 |
| Other Operating Activity | 21,885 | -15,552 | 84,285 | 20,711 | 9,235 |
| Operating Cash Flow | $87,123 | $169,447 | $82,305 | $108,739 | $105,276 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -14,750 | -15,525 | -24,713 | -9,053 | -5,910 |
| Net Acquisitions | 2,747 | 558,067 | -1,062,818 | 1,416 | N/A |
| Sale Of Investment | 2,728 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -6,697 | -1,499 | 0 | 0 | 0 |
| Investing Cash Flow | $-15,972 | $541,043 | $-1,087,531 | $-7,637 | $-5,910 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 2,533 |
| Debt Issued | 398,000 | 196,525 | 1,611,970 | 253,425 | 373,450 |
| Debt Repayment | -502,275 | -795,100 | -574,329 | -373,536 | -449,084 |
| Common Stock Issued | 686 | 1,025 | 989 | 1,910 | 5,722 |
| Common Stock Repurchased | -751 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -7,064 | -15,041 | -32,839 | -9,352 | -6,933 |
| Financing Cash Flow | $-111,404 | $-612,591 | $1,005,791 | $-127,553 | $-74,312 |
| Exchange Rate Effect | N/A | N/A | -12 | -56 | 1,784 |
| Beginning Cash Position | 100,385 | 2,486 | 1,933 | 28,440 | 1,602 |
| End Cash Position | 60,132 | 100,385 | 2,486 | 1,933 | 28,440 |
| Net Cash Flow | $-40,253 | $97,899 | $553 | $-26,507 | $26,838 |
| Free Cash Flow | |||||
| Operating Cash Flow | 87,123 | 169,447 | 82,305 | 108,739 | 105,276 |
| Capital Expenditure | -14,750 | -15,525 | -24,713 | -9,053 | -5,910 |
| Free Cash Flow | 72,373 | 153,922 | 57,592 | 99,686 | 99,366 |